Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
- PMID: 1614046
- DOI: 10.1038/ki.1992.195
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Abstract
Autosomal-dominant polycystic kidney disease results in renal failure at a varying age from childhood to old age. We postulated that factors other than the culprit gene alone contribute to the course of progression of the renal failure. We studied 580 subjects with autosomal-dominant polycystic kidney disease and 194 unaffected family members. We calculated survival curves to end-stage renal failure or death and developed a linear model for testing the effects of single or multiple variables on the progression of renal failure as estimated from the reciprocal of serum creatinine. Fifty-two subjects died and 94 reached end-stage renal failure during the period of observation, yielding functional survivals of 71% at age 50 years, 53% at 58 years and 23% at 70 years. The following variables were independently associated with worse mean renal function at a given age (P value less than 0.01): the PKD1 gene, younger age at diagnosis, male gender, hypertension, increased left ventricular mass, hepatic cysts in women, three or more pregnancies, gross hematuria, urinary tract infections in men and renal size expressed as renal volume. The following were not associated significantly with the course of renal function: gender of affected parent, mitral valve prolapse, intracranial aneurysms, any pregnancy, hepatic cysts in men and urinary tract infections in women. The identification of unalterable maleficent factors such as the PKD1 gene and male gender permit more informed counseling while the identification of alterable factors such as hypertension, number of pregnancies and recurrent urinary tract infections provides the clinician with the opportunity to modify these factors and improve the management of patients with autosomal-dominant polycystic kidney disease.
Similar articles
-
Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease.J Am Soc Nephrol. 1997 Oct;8(10):1560-7. doi: 10.1681/ASN.V8101560. J Am Soc Nephrol. 1997. PMID: 9335384
-
Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease.Hepatology. 1990 Jun;11(6):1033-7. doi: 10.1002/hep.1840110619. Hepatology. 1990. PMID: 2365280
-
Renal and extrarenal manifestations of autosomal dominant polycystic kidney disease.Braz J Med Biol Res. 2006 Apr;39(4):533-8. doi: 10.1590/s0100-879x2006000400014. Epub 2006 Apr 3. Braz J Med Biol Res. 2006. PMID: 16612477
-
Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease.Am J Kidney Dis. 2018 Dec;72(6):866-872. doi: 10.1053/j.ajkd.2018.01.048. Epub 2018 Mar 30. Am J Kidney Dis. 2018. PMID: 29606500 Review.
-
Autosomal Dominant Polycystic Kidney Disease.Prim Care. 2020 Dec;47(4):673-689. doi: 10.1016/j.pop.2020.08.010. Prim Care. 2020. PMID: 33121636 Review.
Cited by
-
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience.Clin Exp Nephrol. 2013 Jun;17(3):345-51. doi: 10.1007/s10157-012-0706-3. Epub 2012 Oct 20. Clin Exp Nephrol. 2013. PMID: 23085781
-
Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.Clin Exp Nephrol. 2019 Oct;23(10):1188-1195. doi: 10.1007/s10157-019-01752-3. Epub 2019 Jun 5. Clin Exp Nephrol. 2019. PMID: 31165946
-
PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease.Biomolecules. 2023 Jun 21;13(7):1020. doi: 10.3390/biom13071020. Biomolecules. 2023. PMID: 37509056 Free PMC article.
-
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.Kidney Int. 2019 Jul;96(1):159-169. doi: 10.1016/j.kint.2018.11.044. Epub 2019 Mar 9. Kidney Int. 2019. PMID: 30898339 Free PMC article. Clinical Trial.
-
Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach.Am J Hum Genet. 1997 Jun;60(6):1399-410. doi: 10.1086/515467. Am J Hum Genet. 1997. PMID: 9199561 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources